omeprazole and gsk1325756

omeprazole has been researched along with gsk1325756 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambery, CL; Bloomer, JC; Connolly, P; Lazaar, AL; Miller, BE; Mistry, S; Sanderson, D; Shreeves, T; Smart, K; Smith, R1
Bloomer, JC; Carpenter, DC; Connolly, P; Cooray, H; Lazaar, AL; Miller, BE; Mistry, S; Smart, K; Tal-Singer, R1
Ambery, C; Bloomer, J; Lazaar, AL; Leidy, N; Miller, BE; Tabberer, M; Tal-Singer, R; Watz, H; Yonchuk, J1

Trials

3 trial(s) available for omeprazole and gsk1325756

ArticleYear
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.
    European journal of drug metabolism and pharmacokinetics, 2014, Volume: 39, Issue:3

    Topics: Administration, Oral; Age Factors; Aged; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Interactions; England; Fasting; Female; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Piperidines; Postprandial Period; Proton Pump Inhibitors; Respiratory System Agents; Solubility; Sulfones; Tablets

2014
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.
    BMC pharmacology & toxicology, 2015, Jun-20, Volume: 16

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; CD11b Antigen; Chemokine CXCL1; Dose-Response Relationship, Drug; Double-Blind Method; Food; Healthy Volunteers; Humans; Male; Middle Aged; Neutrophils; Omeprazole; Piperidines; Receptors, Interleukin-8B; Sulfones; Young Adult

2015
Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
    The European respiratory journal, 2018, Volume: 52, Issue:4

    Topics: Administration, Oral; Aged; Female; Health Status; Humans; Male; Middle Aged; Omeprazole; Piperidines; Pulmonary Disease, Chronic Obstructive; Receptors, Interleukin-8B; Sulfones; Treatment Outcome

2018